Jeil Pharmaceutical Co.,Ltd (271980.KS)

KRW 11640.0

(-5.6%)

Total Liabilities Summary of Jeil Pharmaceutical Co.,Ltd

  • Jeil Pharmaceutical Co.,Ltd's latest annual total liabilities in 2023 was 330.29 Billion KRW , up 9.63% from previous year.
  • Jeil Pharmaceutical Co.,Ltd's latest quarterly total liabilities in 2024 Q2 was 304.51 Billion KRW , down -8.81% from previous quarter.
  • Jeil Pharmaceutical Co.,Ltd reported annual total liabilities of 301.29 Billion KRW in 2022, up 16.27% from previous year.
  • Jeil Pharmaceutical Co.,Ltd reported annual total liabilities of 259.13 Billion KRW in 2021, up 9.26% from previous year.
  • Jeil Pharmaceutical Co.,Ltd reported quarterly total liabilities of 304.51 Billion KRW for 2024 Q2, down -8.81% from previous quarter.
  • Jeil Pharmaceutical Co.,Ltd reported quarterly total liabilities of 313.77 Billion KRW for 2023 Q1, up 4.14% from previous quarter.

Annual Total Liabilities Chart of Jeil Pharmaceutical Co.,Ltd (2023 - 2015)

Historical Annual Total Liabilities of Jeil Pharmaceutical Co.,Ltd (2023 - 2015)

Year Total Liabilities Total Liabilities Growth
2023 330.29 Billion KRW 9.63%
2022 301.29 Billion KRW 16.27%
2021 259.13 Billion KRW 9.26%
2020 237.18 Billion KRW 2.44%
2019 231.54 Billion KRW 6.23%
2018 217.96 Billion KRW -7.54%
2017 235.73 Billion KRW -1.74%
2016 239.9 Billion KRW 17.73%
2015 203.77 Billion KRW 0.0%

Peer Total Liabilities Comparison of Jeil Pharmaceutical Co.,Ltd

Name Total Liabilities Total Liabilities Difference
Yuyu Pharma, Inc. 77.85 Billion KRW -324.227%
Dong-A Socio Holdings Co., Ltd. 929.79 Billion KRW 64.477%
Ildong Holdings Co., Ltd. 707.09 Billion KRW 53.289%
HANDOK Inc. 449.7 Billion KRW 26.553%
Kukje Pharma Co., Ltd. 85.67 Billion KRW -285.541%
Yuhan Corporation 712.33 Billion KRW 53.632%
Dong-A ST Co., Ltd. 631.91 Billion KRW 47.731%
SAMSUNG PHARM. Co., LTD. 15.89 Billion KRW -1978.042%
Hanmi Pharm. Co., Ltd. 851.82 Billion KRW 61.225%
Hanall Biopharma Co.,Ltd 53.52 Billion KRW -517.042%
Ilyang Pharmaceutical Co.,Ltd 205.87 Billion KRW -60.434%
Dong Sung Bio Pharm.Co.,Ltd. 75.17 Billion KRW -339.391%
MYUNGMOON Pharm co.,Ltd 147.79 Billion KRW -123.482%
Hana Pharm Co., Ltd. 70.4 Billion KRW -369.159%
Yuyu Pharma, Inc. 77.85 Billion KRW -324.227%
Ilsung Pharmaceuticals Co., Ltd. 36.43 Billion KRW -806.499%
REYON Pharmaceutical Co., Ltd. 251.15 Billion KRW -31.512%
Aprogen pharmaceuticals,Inc. 220.7 Billion KRW -49.654%
JW Holdings Corporation 827.51 Billion KRW 60.086%
Ildong Pharmaceutical Co., Ltd. 436.99 Billion KRW 24.417%
Chong Kun Dang Pharmaceutical Corp. 586.79 Billion KRW 43.712%
JW Pharmaceutical Corporation 379.59 Billion KRW 12.989%
Shin Poong Pharm.Co.,Ltd. 79.3 Billion KRW -316.504%
Hyundai Pharmaceutical Co., Ltd. 69.96 Billion KRW -372.067%
Samil Pharmaceutical Co.,Ltd 242.85 Billion KRW -36.006%
Yuyu Pharma, Inc. 77.85 Billion KRW -324.227%
Kwang Dong Pharmaceutical Co., Ltd. 490.01 Billion KRW 32.596%
Daewoong pharmaceutical Co.,Ltd 858.02 Billion KRW 61.506%
JW Pharmaceutical Corporation 379.59 Billion KRW 12.989%
Yuhan Corporation 712.33 Billion KRW 53.632%
Jeil Pharma Holdings Inc 477.81 Billion KRW 30.873%
Yungjin Pharm. Co., Ltd. 136.96 Billion KRW -141.146%
Suheung Co., Ltd. 516.66 Billion KRW 36.072%
JW Pharmaceutical Corporation 379.59 Billion KRW 12.989%
Samjin Pharmaceuticals Co., Ltd. 154.53 Billion KRW -113.732%
Korea United Pharm Inc. 89.96 Billion KRW -267.135%
CKD Bio Corp. 170.76 Billion KRW -93.425%
Daewon Pharmaceutical Co., Ltd. 243.73 Billion KRW -35.514%
Dongwha Pharm.Co.,Ltd 157.65 Billion KRW -109.502%
Whan In Pharm Co.,Ltd. 43.01 Billion KRW -667.784%
Shin Poong Pharm.Co.,Ltd. 79.3 Billion KRW -316.504%
Chong Kun Dang Holdings Corp. 632.51 Billion KRW 47.781%
Boryung Corporation 373.1 Billion KRW 11.475%
Bukwang Pharmaceutical Co., Ltd. 208.19 Billion KRW -58.645%
Ilyang Pharmaceutical Co.,Ltd 205.87 Billion KRW -60.434%
JW Lifescience Corporation 96.44 Billion KRW -242.475%